![Martin Gouldstone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Gouldstone
Algemeen Directeur bij
ONCE HLDG
Vermogen: 3 978 $ op 31-07-2026
Profiel
Mr. Martin J.
Gouldstone is an Independent Non-Executive Chairman at ValiRx Plc, a Chief Executive Officer at Oncimmune Holdings Plc, an Independent Non-Executive Director at hVIVO Holdings Ltd. and a Chief Executive Officer at Oncimmune Germany GmbH.
He is on the Board of Directors at hVIVO Holdings Ltd. Mr. Gouldstone was previously employed as an Independent Non-Executive Director by hVIVO PLC, a Global Senior Vice President-Business Development by Owkin, Inc., a Chief Business Development Officer by Sensyne Health Ltd., a Chief Business Officer by BenevolentAI SA, a Partner by Results Healthcare, a Director-Corporate Advisory & Head-Life Sciences by BDO UK LLP, and a Director-Business Development by Sareum Ltd. He also served on the board at Orthopaedic Research UK and Novara Therapeutics Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VALIRX PLC 0,15% | 21-11-2025 | 1.969.231 ( 0,15% ) | 3 978 $ | 31-07-2026 |
Actieve functies van Martin Gouldstone
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCE HLDG | Algemeen Directeur | 01-08-2023 |
| HVIVO PLC | Directeur/Bestuurslid | 01-06-2022 |
| VALIRX PLC | Voorzitter | 25-07-2024 |
Oncimmune Germany GmbH
 Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Algemeen Directeur | - |
Eerdere bekende functies van Martin Gouldstone
| Bedrijven | Functie | Einde |
|---|---|---|
| HVIVO PLC | Directeur/Bestuurslid | 05-06-2025 |
Orthopaedic Research UK
 Orthopaedic Research UK Miscellaneous Commercial ServicesCommercial Services Provides business support services | Directeur/Bestuurslid | 01-03-2024 |
| SENSYNE HEALTH PLC | Corporate Officer/Principal | 01-05-2022 |
| BENEVOLENTAI S.A. | Corporate Officer/Principal | 01-01-2019 |
Results Healthcare
 Results Healthcare Investment ManagersFinance Provides advisory services | Corporate Officer/Principal | 01-06-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
51
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
ValiRx Plc
 ValiRx Plc Pharmaceuticals: MajorHealth Technology Develops novel technologies and products in oncology therapeutics and diagnostics | Health Technology |
hVIVO Holdings Ltd.
 hVIVO Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Provides drug discovery services | Retail Trade |
Results Healthcare
Results Healthcare Investment ManagersFinance Provides advisory services | Finance |
Oncimmune Holdings Plc
 Oncimmune Holdings Plc BiotechnologyHealth Technology Provides cancer detection and diagnosis services | Health Technology |
Orthopaedic Research UK
Orthopaedic Research UK Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Owkin, Inc.
 Owkin, Inc. Packaged SoftwareTechnology Services Develops AI technology that accelerates drug discovery by combining multimodal patient data and large language models | Technology Services |
Sensyne Health Ltd.
 Sensyne Health Ltd. Miscellaneous Commercial ServicesCommercial Services Provides statistical analyses and advanced insights to the healthcare industry | Commercial Services |
BDO UK LLP
 BDO UK LLP Miscellaneous Commercial ServicesCommercial Services Provides tax, audit & assurance, advisory and business outsourcing services | Commercial Services |
hVIVO PLC
 hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services | Commercial Services |
Oncimmune Germany GmbH
Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Health Technology |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
